Cite
HARVARD Citation
He, Y. et al. (2022). Dasatinib‐therapy induced sustained remission in a child with refractory TCF7‐SPI1 T‐cell acute lymphoblastic leukemia. Pediatric blood & cancer. 69 (8), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
He, Y. et al. (2022). Dasatinib‐therapy induced sustained remission in a child with refractory TCF7‐SPI1 T‐cell acute lymphoblastic leukemia. Pediatric blood & cancer. 69 (8), p. n/a. [Online].